What is the address of MYMED?

The registered office of MYMED is located at Rue de l'Avenir 14, 4450 Juprelle.

Is MYMED still active?

Yes. According to the CBE (30 October 2026) MYMED is active, legal situation “Normale toestand”, started on 27 July 2020.

Is MYMED registered on Peppol?

No, MYMED is currently not registered on the Peppol network.

What is the enterprise number of MYMED?

The enterprise number of MYMED is BE0751507203.

When was MYMED founded?

MYMED was founded on 27 July 2020.

Is MYMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 July 2020; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MYMED make in 2025?

MYMED posted a profit after taxes of € 127,221 in financial year 2025.

What is the revenue of MYMED?

As a small company, MYMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 195,508.

MYMED (Private Limited) - Juprelle - BE0751507203

Dossier MYMED, printed on 30 October 2026 from databakkes.be/en/0751507203/mymed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MYMED from Juprelle, company number BE0751507203, closed financial year 2025 with a result of € 127,221 after tax. For that financial year MYMED recorded a gross margin of € 195,508 and equity of € 139,305. Compared with financial year 2024, the result moved from € 118,021 to € 127,221. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Growing

€ 139,305

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 127,221

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 192,022

▲ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 117,647 paid out

92 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 18,381

▼ 11% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 16 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 295,090

▼ 6% vs 2024

€ 18,273 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.

Owed to suppliers

€ 3,616

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 81,796

▲ 83% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 131,849 Gross margin 2022: € 131,849 First fiscal year in the series	€ 73,054 Gross margin 2023: € 73,054 ▼ 45% vs 2022 (€ 131,849) Unfavourable step	€ 179,258 Gross margin 2024: € 179,258 ▲ 145% vs 2023 (€ 73,054) Favourable step	€ 195,508 Gross margin 2025: € 195,508 ▲ 9% vs 2024 (€ 179,258) Favourable step	▲ 9%
Profit after taxes	€ 102,209 Profit after taxes 2022: € 102,209 First fiscal year in the series	€ 50,073 Profit after taxes 2023: € 50,073 ▼ 51% vs 2022 (€ 102,209) Unfavourable step	€ 118,021 Profit after taxes 2024: € 118,021 ▲ 136% vs 2023 (€ 50,073) Favourable step	€ 127,221 Profit after taxes 2025: € 127,221 ▲ 8% vs 2024 (€ 118,021) Favourable step	▲ 8%
Equity	€ 116,784 Equity 2022: € 116,784 First fiscal year in the series	€ 129,357 Equity 2023: € 129,357 ▲ 11% vs 2022 (€ 116,784) Favourable step	€ 129,731 Equity 2024: € 129,731 Unchanged (€ 129,357) Favourable step	€ 139,305 Equity 2025: € 139,305 ▲ 7% vs 2024 (€ 129,731) Favourable step	▲ 7%
Total debts	€ 29,359 Total debts 2022: € 29,359 First fiscal year in the series	€ 233,848 Total debts 2023: € 233,848 ▲ € 204,489 vs 2022 (€ 29,359) Unfavourable step	€ 465,449 Total debts 2024: € 465,449 ▲ 99% vs 2023 (€ 233,848) Unfavourable step	€ 485,796 Total debts 2025: € 485,796 ▲ 4% vs 2024 (€ 465,449) Unfavourable step	▲ 4%
Cash	€ 115,981 Cash 2022: € 115,981 First fiscal year in the series	€ 107,181 Cash 2023: € 107,181 ▼ 8% vs 2022 (€ 115,981) Unfavourable step	€ 184,874 Cash 2024: € 184,874 ▲ 72% vs 2023 (€ 107,181) Favourable step	€ 192,022 Cash 2025: € 192,022 ▲ 4% vs 2024 (€ 184,874) Favourable step	▲ 4%
Land & buildings	-	€ 222,598 Land & buildings 2023: € 222,598 First fiscal year in the series	€ 354,296 Land & buildings 2024: € 354,296 ▲ 59% vs 2023 (€ 222,598) Unchanged	€ 348,028 Land & buildings 2025: € 348,028 ▼ 2% vs 2024 (€ 354,296) Unchanged	▼ 2%
Retained profit	€ 114,284 Retained profit 2022: € 114,284 First fiscal year in the series	€ 126,857 Retained profit 2023: € 126,857 ▲ 11% vs 2022 (€ 114,284) Favourable step	€ 127,231 Retained profit 2024: € 127,231 Unchanged (€ 126,857) Favourable step	€ 136,805 Retained profit 2025: € 136,805 ▲ 8% vs 2024 (€ 127,231) Favourable step	▲ 8%
Dividend	€ 14,286 Dividend 2022: € 14,286 First fiscal year in the series	€ 37,500 Dividend 2023: € 37,500 ▲ 162% vs 2022 (€ 14,286) Unchanged	€ 117,647 Dividend 2024: € 117,647 ▲ 214% vs 2023 (€ 37,500) Unchanged	€ 117,647 Dividend 2025: € 117,647 Unchanged (€ 117,647) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 190,193 Bank debt 2023: € 190,193 Unchanged (€ 0) Unfavourable step	€ 312,649 Bank debt 2024: € 312,649 ▲ 64% vs 2023 (€ 190,193) Unfavourable step	€ 295,090 Bank debt 2025: € 295,090 ▼ 6% vs 2024 (€ 312,649) Favourable step	▼ 6%
Balance sheet total	€ 146,143 Balance sheet total 2022: € 146,143 First fiscal year in the series	€ 363,205 Balance sheet total 2023: € 363,205 ▲ 149% vs 2022 (€ 146,143) Unchanged	€ 595,180 Balance sheet total 2024: € 595,180 ▲ 64% vs 2023 (€ 363,205) Unchanged	€ 625,101 Balance sheet total 2025: € 625,101 ▲ 5% vs 2024 (€ 595,180) Unchanged	▲ 5%

Key figures of MYMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MYMED?

What happened at MYMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 11, 2026 New annual accounts for financial year 2025: profit of € 127,221 (▲ 8% vs 2024). Source: NBB ↗
Jan 1, 2021 New establishment in Juprelle. KBO
Jul 27, 2020 Start of the company according to the CBE. KBO

In short

From € 102,209 profit in 2022 to € 127,221 profit in 2025.

Paid € 115,124 in corporate taxes since 2022.

Best year ever: 2025, with € 127,221 profit.

Paid out € 287,080 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de l'Avenir 14

4450 Juprelle

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0751.507.203
VAT number: BE 0751.507.203
Registered office: Rue de l'Avenir 14, 4450 Juprelle
Names & denominations: MYMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 July 2020
Peppol: Not registered
Contact: [email protected] +32492794629

View on CBE Public ↗ Annual accounts (NBB) ↗

MYMED